ImmixBio announces FDA Orphan drug designation for IMX-110 for the treatment of Soft Tissue Sarcoma

Latest pharma news update

Immix Biopharma, Inc., a biotechnology company pioneering Tissue-Specific Therapeutics (TSTx)TM for oncology and inflammation, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to IMX-110 for the treatment of soft tissue sarcoma.

The FDA’s Office of Orphan Products Development grants orphan designation status to drugs and biologics that are intended for the safe and effective treatment, diagnosis or prevention of rare diseases, or conditions that affect fewer than 200,000 people in the U.S. Orphan Drug Designation provides certain benefits, including financial incentives, to support clinical development and the potential for up to 7 years of market exclusivity in the U.S. upon regulatory approval.

“We are pleased to receive FDA’s orphan drug designation in soft tissue sarcoma for IMX-110, the first clinical-stage product of our SMARxT Tissue-Specific Platform,” said Ilya Rachman MD PhD, ImmixBio Founder & CEO. “We are thrilled to potentially contribute to expanding therapeutic options for oncology patients, beginning with soft tissue sarcoma.”

Gabriel Morris, ImmixBio Chief Financial Officer, added: “Orphan drug designation for IMX-110 represents a substantial value creating step along our path of building a strong, independent biopharmaceutical organization.”

Tags : #Immixbio #SoftTissueSarcoma #IMX110 #FDANews #FDAApprovalsLatest

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

From Gram Sabha to Health Fair: Panvel's Ayushman Bhava JourneyOctober 03, 2023
World Heart Day in India: A Symphony of Heart HealthOctober 03, 2023
Breathing Easy: A Deep Dive into Chronic Obstructive Pulmonary Disease (COPD)October 03, 2023
Freedom Healthy Cooking Oils distributes Seed Ganesha Idols for an eco-friendly festival September 28, 2023
Sadar Hospital,Ranchi Extends Free Cancer Care through Ayushman Bharat Scheme: A ray of hopeSeptember 28, 2023
Dopamine and Its Impact on Your Brain, Feelings, and EmotionsSeptember 28, 2023
Ayushman Bharat-PMJAY: Transforming Healthcare for Millions in IndiaSeptember 28, 2023
Premature Greying of Hair: preventing in the Indian styleSeptember 28, 2023
Run organised to create awareness for Cerebral PalsySeptember 27, 2023
16 Visually challenged explored Skill Development and Employment opportunities in interactive session at FTCCI September 26, 2023
FUJIFILM India celebrates 125 Digital Mammography Machine Installation milestone at the 3rd edition of 'Together Against Breast Cancer' ConferenceSeptember 26, 2023
AI4Rx, the AI powered medical care platform, announces the launch of MedBeat HealthConnectSeptember 26, 2023
Foetal medicine taking rapid strides to optimise Foetal outcomes!September 26, 2023
NGOs bring access to primary health services between 0-3kms for residents of Slums under Jalpally Municipality in line with the UN SDP and Universal Health Coverage modelSeptember 26, 2023
Oliva Skin & Hair Clinic, launches its 25th Clinic in India and 7th in the city, at Dilsukhnagar!September 26, 2023
Badminton sensation Shashidhar brings honor to Telangana and India by clinching the Silver medal at the BWF World Senior Championship in Korea!September 26, 2023
5 Best Homemade Juices to Drink Every Day for a Healthier YouSeptember 26, 2023
Traditionally, men were seen as more profit-oriented in business, but now women are proving they are equally capable - Rahul Jain, a top Indian business coach.September 25, 2023
4-Year-Old Girl Gets New lease of life at American Oncology Institute (AOI) Hyderabad with Haploidentical Stem Cell Transplantation September 25, 2023
Silver Oaks International Schools to provide succor to the underprivileged through its ‘Silver Oaks Street Store’ initiative!September 25, 2023